Three scientists describe the fieldwork they’ve had to delay in 2020 because of the pandemic. These are setbacks not just for their careers, but for the body of scientific knowledge.
The second (and third) wave of the pandemic continues as the end-of-year holiday season approaches. Here are strategies to fight Zoom fatigue while staying virtually close to your loved ones.
Calls for help to domestic violence shelters have risen during the pandemic, as risk factors for the escalation of violence have gone up. It may be time to implement new strategies to help.
With new US COVID-19 cases topping 200,000 a day, contact tracers are overwhelmed. Here’s how infected people can start tracing and notifying contacts themselves.
A pharmaceutical supply chain expert explains the challenges of distributing the COVID-19 vaccines from Pfizer and Moderna that need to be kept at very low temperatures.
Indonesia is paying the price for failing to control the spread of the coronavirus. The country needs to change course and give priority to public health as the first step in repairing the economy.
With a vaccine now approved in the UK, other countries won’t be far behind. But a vaccine won’t singlehandedly ensure the virus doesn’t cross international borders when travel picks up.
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
The side effects of new SARS-CoV-2 vaccines are a result of immune system activation. While uncomfortable, they are both normal and expected. They are a sign that the vaccine is working.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand